Breaking News

Sen-Jam Pharmaceutical Enters Strategic Partnership with KVK-Tech

KVK-Tech to provide formulation and Chemistry, Manufacturing & Controls (CMC) for Sen-Jam's injectable anti-inflammatory therapeutic.

Author Image

By: Charlie Sternberg

Associate Editor

Sen-Jam Pharmaceutical, a life sciences company developing a portfolio of anti-inflammatories by repurposing existing molecules for novel uses, has entered a third strategic partnership with KVK-Tech, a Specialty Pharmaceutical Manufacturing company that will be providing formulation and Chemistry, Manufacturing & Controls (CMC) for Sen-Jam’s first injectable anti-inflammatory therapeutic, SJP-100.   SJP-100 is an immunomodulator with a unique, dual mechanism of action. Its formulati...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters